Tyrosine kinase 2 (TYK2) is another key regulator of type I and type III IFN signalling, and gene variants predicted to decrease TYK2 functionality are associated with a reduced risk of T1D and other autoimmune conditions [88]. This evidence concerns the gene TYK2 and Autoimmunity.